Clinical Trial Update: Stem Cell Transplant for Hemoglobinopathy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update on stem cell transplant for hemoglobinopathy shows completed status with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Thalassemia

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Sickle Cell Disease, Thalassemia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-05-09